Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma (Q43299263)

From Wikidata
Jump to navigation Jump to search
scientific article published on 3 August 2009
edit
Language Label Description Also known as
English
Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma
scientific article published on 3 August 2009

    Statements

    Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit